Student research project
Supervisors: Professor Peter Meikle, Dr Sudip Paul, Dr Satvika Burugupalli
The Metabolomics Laboratory uses state-of-the-art tandem mass spectrometry to obtain metabolic/lipid profiles from cell and animal models in addition to clinically relevant human samples to develop new approaches to diagnosis, risk assessment and therapy for diabetes and cardiovascular disease.
Breastfeeding, the biological norm of feeding babies, provides numerous health benefits to babies. Infant-formula-feeding is thought to be inferior to breastfeeding because human milk provides specific and non-specific factors that have long-term consequences for early metabolism and the development of diseases1. However, the 20th century witnessed an increase in formula feeding. Currently, only 35% of infants are exclusively breastfed in the first six months of their life.
Lipids make up 3–5% of the composition of human breast milk. Besides providing energy, breast milk lipids are also necessary for the infant growth and development2. We have recently performed the largest plasma lipidomic profiling study of mothers and infants from the Barwon Infant Study (BIS) and observed that ether lipid species were markedly elevated in infants who were breastfed compared to those who were not. We have also profiled breast milk samples available from BIS and several infant formulae and found that breast milk has a clearly distinct lipidome compared to infant formulae. In particular, breast milk has significantly higher ether lipid content compared to infant formulae. Ether lipids are a class of lipids with unique structural feature and are thought to have anti-oxidant, anti-inflammatory and immunomodulatory properties3.
We hypothesise that breast milk ether lipids can modulate immune cell function and thereby help in the development of immunity in infants. The aim of this project is to determine the effects of modifying the ether lipid content of milk (a) on the immune cell lipidomes and (b) on the susceptibility of these immune cells to pathogenic stimuli such as oxidative stress and inflammation in a murine model.
We will generate a unique genetically modified mouse model to deplete the content of ether lipids in mouse milk. We will also supplement pregnant and lactating mice with alkylglycerols (naturally occurring precursors that can be metabolised into endogenous ether lipids) to modify the milk ether lipid content in different magnitudes. We will characterise the milk samples using our state of the art liquid-chromatography mass spectrometry based lipidomics method to confirm the modification of ether lipid content in mouse milk. We will also characterise the lipidomes of plasma, different immune cell types and several tissues of newborn mouse pups (before they transition onto solid food) to examine how modification of ether lipid content in milk affects pups’ endogenous lipidomes. We will also examine the susceptibility of different immune cell sub-types from newborn pups exposed to different levels of milk ether lipids to oxidative cell death and inflammation.
In this project we will combine our lipidomics expertise with our unique mouse models of ether lipid modification to define the role of breast milk ether lipids in modulating immune function in infants.
This project is suitable for an Honours or PhD student.
Browse all postgraduate research opportunities
- Breastfeeding, the immune response, and long-term health. The Journal of the American Osteopathic Association 2006;106(4):203–7.
- Human milk composition: nutrients and bioactive factors. Paediatric clinics of North America 2013;60(1):49–74.
- Plasmalogens: a potential therapeutic target for neurodegenerative and cardiometabolic disease. Progress in Lipid Research 2019;74(9):186–95.